Meeting
2024 ASCO Genitourinary Cancers Symposium
Utilization of genetic counseling and testing for patients with prostate cancer following integration of a genetic counselor into a genitourinary cancer clinic.
Authors
Lindsey Byrne
The Ohio State University, Columbus, OH
Lindsey Byrne , Mckenna Lewis , Shihua Wang , Steven K. Clinton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 343)
DOI
10.1200/JCO.2024.42.4_suppl.343
Abstract #
343
Poster Bd #
P12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Technology-enhanced acceleration of germline evaluation for therapy (TARGET): Results of a randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
First Author: Veda N. Giri
Poster
2023 ASCO Annual Meeting
Geographical impact on prostate cancer genetic testing eligibility: A preliminary study from an academic cancer center.
First Author: Samantha Beck
Poster
2023 ASCO Annual Meeting
Using patient-reported outcomes to assess the impact of germline genetic testing on prostate cancer patients.
First Author: Sarah M. Nielsen
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of pretest video genetic education in prostate cancer patients: Do patients need us?
First Author: Samantha Greenberg